Environmental agents that have the potential to trigger massive apoptotic neurodegeneration in the developing brain

Environmental Health Perspectives

Volumn 108, Issue SUPPL. 3, 2000, Pages 383-388

  Olney, John W ^a   Farber, Nuri B ^a   Wozniak, David F ^a   Jevtovic Todorovic, Vesna ^a   Ikonomidou, Chrysanthy ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Anesthetics; Apoptosis; Barbiturates; Benzodiazepines; Ethanol; GABA(A) receptors; Ketamine; NMDA receptors; Phencyclidine; Synaptogenesis

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ALCOHOL; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; DIAZEPAM; DIZOCILPINE; EXCITOTOXIN; GLUTAMIC ACID; HALOTHANE; ISOFLURANE; KAINIC ACID; KETAMINE; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER; NITROUS OXIDE; PENTOBARBITAL; PHENCYCLIDINE; PHENOBARBITAL; PROPOFOL; SEDATIVE AGENT; TRANQUILIZER;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; BEHAVIOR DISORDER; BRAIN DEVELOPMENT; BRAIN WEIGHT; CONTROLLED STUDY; DRUG ABUSE; DRUG MECHANISM; FETAL ALCOHOL SYNDROME; HUMAN; NERVE CELL; NERVE DEGENERATION; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; SYNAPTOGENESIS; THIRD TRIMESTER PREGNANCY;

EID: 0033926490     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108s3383     Document Type: Article

References (54)

1. Olney JW. Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate. Science 164:719-721 (1969).
2. Olney JW, Price MT. Excitotoxic amino acids as neuroendocrine research tools In: Methods in Enzymology. Vol 103 (Conn PM, ed). New York:Academic Press, 1983;379-393.
3. Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19:105-111 (1986).
4. Olney JW. Excitatory amino acids and neuropsychiatric disorders. Biol Psychiatry 26:505-525 (1989).
5. Choi DW. Excitotoxic cell death. J Neurobiol 23:1261-1276 (1992).
6. Olney JW, Labruyere J, Price MT. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244: 1360-1362 (1989).
7. Fix AS, Long GG, Wozniak DF, Olney JW. Pathomorphologic effects of N-methyl-D-aspartate antagonists in the rat posterior cingulate/retrosplenial cerebral cortex. Drug Dev Res 24:147-152 (1994).
8. Ellison G. Competitive and non-competitive NMDA antagonists induce similar limbic degeneration. Neuroreport 5:2688-2692 (1994).
9. Corso TD, Sesma MA, Tenkova TI, Der TC, Wozniak DF, Farber NB, Olney JW. Multifocal brain damage induced by phencyclidine is augmented by pilocarpine. Brain Res 752:1-14 (1997).
10. Horvath Z, Czopf J, Buzsaki G. MK-801-induced neuronal damage in rats Brain Res 753:181-195 (1997).
11. Wozniak DF, Dikranian K, Ishimaru M, Nardi A, Corso TD, Olney JW, Fix AS. Disseminated corticolimbic neuronal degeneration induced in rat brain by MK801. Neurobiol Dis 5:305-322 (1999).
12. Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma MA. NMDA antagonist neurotoxicity: mechanism and prevention. Science 254:1515-1518 (1991).
13. Ishimaru M, Fukamauchi F, Olney JW. Halothane prevents MK801 neurotoxicity in the rat cingulate cortex. Neurosci Lett 193:1-4 (1995).
14. Jevtovic-Todorovic V, Kirby CO, Olney JW. Isoflurane and propofol block neurotoxicity caused by MK801 in the rat posterior cingulate/retrosplenial cortex. J Cereb Blood Flow Metab 17:168-174 (1997).
15. Olney JW, Farber NB. Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity. J Clin Psychiatry 55(suppl B):43-46 (1994).
16. 2 adrenergic agonists prevent MK801 neurotoxicity. Neuropsychopharmacology 12(4):347-349 (1995).
17. 2A receptors prevent NMDA antagonist neurotoxicity. Neuropsychopharmacology 18(1):57-62 (1998).
18. Jevtovic-Todorovic V, Olney JW, Farber NB. Lamotrigine prevents NMDA antagonist neurotoxicity. Soc Neurosci Abstr 24:745 (1998).
19. Farber NB, Foster J, Duhan NL, Olney JW. Olanzapine and fluperlapine mimic clozapine in preventing MK801 neurotoxicity. Schizophr Res 21:33-37 (1996).
20. 2-adrenergic agonists. Mol Psychiatry 4:344-352 (1999).
21. Hasegawa M, Kinoshita H, Amano M, Hasegawa T, Kameyama T, Nabeshima T. MK-801 increases endogenous acetylcholine release in the rat parietal cortex: a study using brain microdialysis. Neurosci Lett 150:53-56 (1993).
22. Giovannini MG, Camilli F, Mundula A, Pepeu G. Glutamatergic regulation of acetylcholine output in different brain regions: a microdialysis study in the rat. Neurochem Int 25:23-26 (1994).
23. Giovannini MG, Mutolo D, Blanchi L, Michelassi A, Pepeu G. NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: a microdialysis study. J Neurosci 14:1358-1365 (1994).
24. Giovannini MG, Giovannelli L, Bianchi L, Kalfin R and Pepeu G. Glutamatergic modulation of cortical acetylcholine release in the rat: a combined in vivo microdialysis, retrograde tracing and immunohistochemical study. Eur J Neurosci 9:1678-1689 (1997).
25. Zhelyazkova-Savova M, Giovannini MG, Pepeu G. Increase of cortical acetylcholine release after systemic administration of chlorophenylpiperazine in the rat: an in vivo microdialysis study. Neurosci Lett 236:151-154 (1997).
26. Adams B, Moghaddam B. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18:5545-5554 (1998).
27. Moghaddam B, Adams BW. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281:1349-1352 (1998).
28. Noguchi K, Johnson R, Ellison G. The effects of MK-801 on aspartate and glutamate levels in the anterior cingulate and retrosplenial cortices an in vivo microdialysis study. Soc Neurosci Abstr 24:233 (1998).
29. Jevtovic-Todorovic V, Newcomer JW, Olney JW, Farber NB. Pilocarpine reverses clozapine's and olanzapine's prevention of NMDA antagonists neurotoxicity (NAN). Soc Neurosci Abstr 25:1817 (1999).
30. Farber NB, Kim SH, Olney JW. Costimulation of muscarinic and non-NMDA glutamate receptors reproduces NMDA antagonist neurotoxicity. Soc Neurosci Abstr 23:2308 (1997).
31. Farber NB, Wozniak DF, Price MT, Labruyere J, Huss J, St. Peter H, Olney JW. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biol Psychiatry 38(12):788-796 (1995).
32. Olney JW, Ishimaru MJ. Excitotoxic cell death. In: Cell Death and Diseases of the Nervous System (Koliatsos VE, Ratan RR, eds). Totowa, NJ:Humana Press, Inc., 1999;197-219.
33. Ishimatu MJ, Ikonomidou C, Tenkova TI, Der TC, Dikranian K, Sesma MA, Olney JW. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J Comp Neurol 408:461-476 (1999).
34. Gwag BJ, Koh JY, Demaro JA, Ying HS, Jacquin M, Choi DW. Slowly triggered excitotoxicity occurs by necrosis in cortical cultures. Neuroscience 77:393-401 (1997).
35. Charriaut-Marlangue C, Ben-Ari Y. A cautionary note on the use of the TUNEL stain to determine apoptosis. Neuroreport 7:61-64 (1995).
36. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 21:1465-468 (1995).
37. Collins RJ, Harmon BV, Gobé GC, Kerr JFR. Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radiat Biol 61:451-453 (1992).
38. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257 (1972).
39. Ikonomidou C, Qin Y, Labruyere J, Kirby C, Olney JW. Prevention of trauma-induced neurodegeneration in infant rat brain. Pediatr Res 39:1020-1027 (1996).
40. Ikonomidou C, Ishimaru M, Bittigau P, Der TC, Qin YQ, Olney JW. Delayed degeneration of distant neurons following neocortical brain concussion in infant rats. Soc Neurosci Abstr 22:20 (1996).
41. Pohl D, Bittigau P, Ishimaru MJ, Stadthaus D, Fuhr S, Voeckler J, Huebner C, Olney JW, Ikonomidou C. Apoptotic cell death triggered by head injury in infant rats is potentiated by NMDA antagonists. Proc Nat Acad Sci USA 96:2508-2513 (1999).
42. Ikonomidou C, Bosch F, Miksa M, Vockler J, Bittigau P, Pohl D, Dikranian K, Tenkova T, Turski L, Olney JW. Blockade of glutamate receptors triggers apoptotic neurodegeneration in the developing brain. Science 283:70-74 (1999).
43. Dobbing J, Sands J. The brain growth sport in various mammalian species. Early Hum Dev 3:79-84 (1979).
44. Lovinger DM, White G. Ethanol potentiation of 5-hydroxytryptamine receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian cells. Mol Pharmacol 40:263-270 (1991).
45. Hoffman PL, Rabe CS, Moses F, Tabakoff B. N-Methyl-D-aspartate receptors and ethanol: Inhibition of calcium flux and cyclic GMP production. J Neurochem 52:1937-1940 (1989).
46. White G, Lovinger DM, Weight FF. Ethanol inhibits NMDA-activated current but does not alter GABA-activated current in an isolated adult mammalian neuron. Brain Res 507:332-336 (1990).
47. Chandler LJ, Guzman NJ, Sumners C, Crews FT. Magnesium and zinc potentiate ethanol inhibition of NMDA-stimulated nitric oxide synthase in cortical neurons. J Pharmacol Exp Ther 271:67-75 (1994).
48. Olney JW, Wozniak DF, Price MT, Ikonomidou C. Alcohol induces massive apoptotic neurodegeneration in the developing rat CNS. Soc Neurosci Abstr 24:1983 (1998).
49. Ikonomidou C, Ishimaru MJ, Wozniak DF, Koch C, Bittigau P, Price MT, Stefovska V, Hörster F, Tenkova T, Dikranian K, et al. Role of ethanol-induced glutamate receptor blockade and resulting apoptotic neurodegeneration in the fetal alcohol syndrome. Science 287:1056-1060 (2000).
50. A receptors blocks neurotoxicity in the adult brain, but augments neurotoxicity in the developing brain. Soc Neurosci Abstr 25:551 (1999).
51. Jevtovic-Todorovic V, Todorovic SM, Mennerick S, Powell S, Dikranian K, Benshoff N, Zorumski CF, Olney JW. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med 4(4):460-463 (1998).
52. Mennerick S, Jevtovic-Todorovic V, Todorovic SM, Shen W, Olney JW, Zorumski CF. Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures. J Neurosci 18:9716-9726 (1998)
53. Famy C, Streissguth AP, Unis AS. Mental illness in adults with fetal alcohol syndrome or fetal alcohol effects. Am J Psych 155:552-554 (1998).
54. Olney JW, Newcomer JW, Farber NB. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 33(6):523-533 (1999).